Corporate Board Profile
Tech Score: 33/100
1 mention(s) identify KATHY LEE-SEPSICK as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| FEMASYS INC | 2022-04-26 | Kathy Lee-Sepsick, our founder, has served as our Chief Executive Officer and President and as Chairman of our board of directors since February 2004. Ms. Lee-Sepsick has served as a senior executive in the medical technologies industry for nearly three decades, compiling a successful track record in growing emerging companies and corporate operating divisions. She holds over 100 patents globally for Femasys products and product candidates. Ms. Lee-Sepsick was instrumental in the various stages of product and company life cycles with strategic, operational, and executive responsibilities, at start-ups Novoste Corporation, developer of intravascular therapy solution and SaluMedica, biomaterial developer of artificial cartilage. At the onset of her career, Ms. Lee-Sepsick served in a product management role at Terumo Medical Corporation, where she was integral in the management of strategic partner, Boston Scientific Corporation. Ms. Lee-Sepsick also serves on the Board of Directors of Georgia Bio. Ms. Lee-Sepsick is a graduate of Rutgers University with an MBA and a BS in Biochemistry. | Holds a BS in Biochemistry and an MBA; has nearly three decades of experience in medical technologies and holds over 100 patents globally for Femasys products and product candidates, indicating strong technical expertise. |
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-26 | Kathy Lee-Sepsick, our founder, has served as our Chief Executive Officer and President and as Chairman of our board of directors since February 2004. Ms. Lee-Sepsick has served as a senior executive in the medical technologies industry for nearly three decades, compiling a successful track record in growing emerging companies and corporate operating divisions. She holds over 100 patents globally for Femasys products and product candidates. Ms. Lee-Sepsick was instrumental in the various stages of product and company life cycles with strategic, operational, and executive responsibilities, at start-ups Novoste Corporation, developer of intravascular therapy solution and SaluMedica, biomaterial developer of artificial cartilage. At the onset of her career, Ms. Lee-Sepsick served in a product management role at Terumo Medical Corporation, where she was integral in the management of strategic partner, Boston Scientific Corporation. Ms. Lee-Sepsick also serves on the Board of Directors of Georgia Bio. Ms. Lee-Sepsick is a graduate of Rutgers University with an MBA and a BS in Biochemistry. |
| 2023-08-07 | Kathy Lee-Sepsick Founder, President and Chief Executive Officer |
| 2024-06-07 | Ms. Lee-Sepsick is a graduate of Rutgers University with an MBA and a BS in Biochemistry. She holds over 100 patents globally for Femasys products and product candidates. |
Data sourced from SEC filings. Last updated: 2026-03-05